BioRestorative Therapies, Inc.

Healthcare · Biotechnology · United States

Last price 1.4003 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.78M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient’s bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to ...